Home > Insider Trading > Filing (0000914190-12-000506)

Filing Details

Accession Number:: 0000914190-12-000506
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-08-20 18:15:14
Reporting Period:: 2012-08-16

Filing Date:: 2012-08-20
Accepted Time:: 2012-08-20 18:15:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1180145	Cardiovascular Systems Inc	CSII	Surgical & Medical Instruments & Apparatus (3841)	411698056

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1304318	David Martin	651 Campus Drive St. Paul MN 55112	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2012-08-16	3,827	$8.73	379,195	No	4	S	Direct
Common Stock	Disposition	2012-08-17	4,451	$8.75	374,744	No	4	S	Direct
Common Stock	Disposition	2012-08-20	4,304	$8.97	370,440	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$8.83	2016-07-16	71,170	71,170	Direct
Common Stock	Stock Option (right to buy)	$8.83	2016-08-14	38,820	38,820	Direct
Common Stock	Stock Option (right to buy)	$8.83	2017-02-14	349,380	349,380	Direct
Common Stock	Stock Option (right to buy)	$7.90	2017-06-11	90,580	90,580	Direct
Common Stock	Stock Option (right to buy)	$12.15	2017-12-11	242,625	242,625	Direct
Common Stock	Stock Option (right to buy)	$8.75	2019-03-01	32,350	32,350	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2016-07-16	71,170	71,170	Direct
2016-08-14	38,820	38,820	Direct
2017-02-14	349,380	349,380	Direct
2017-06-11	90,580	90,580	Direct
2017-12-11	242,625	242,625	Direct
2019-03-01	32,350	32,350	Direct

Footnotes

In connection with the vesting and delivery of restricted stock, shares sold on each date, as well as the sales previously reported on August 15, 2012, were sold and the net proceeds were used to pay required withholding taxes.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.60 to $8.83 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.62 to $8.90 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.79 to $9.06 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Fully exercisable.